Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

9342-8530 Quebec Inc DGCRF

Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.


GREY:DGCRF - Post by User

Comment by so_wrongon Dec 23, 2015 8:38pm
111 Views
Post# 24410313

RE:RE:12 cents

RE:RE:12 centsI totally agree with your mixed feelings Dibah42
I'm under the impression that Axelrod has been in this dog as long as the next guy, so would he not have purchased many of his shares at a much higher price?
It would be very interesting to know what his average purchase price is at.
If he still owns 20% and if his average purchase was around 25 cents, he is in for $2.15 million
If my assumptions are close to correct, (with a name like so_wrong, it is highly unlikely) he will get a cheque for just over a million on this deal, so he just cut his "investment" in half. I highly doubt he'll put that back into this "dog"
Maybe he'll pick up some Hologic shares ;)

S_W
<< Previous
Bullboard Posts
Next >>